These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 11913672)

  • 1. Medical management of obesity associated with mental disorders.
    Malhotra S; McElroy SL
    J Clin Psychiatry; 2002; 63 Suppl 4():24-32. PubMed ID: 11913672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Obesity in patients with severe mental illness: overview and management.
    McElroy SL
    J Clin Psychiatry; 2009; 70 Suppl 3():12-21. PubMed ID: 19570497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Schizophrenia, obesity, and antipsychotic medications: what can we do?
    Citrome L; Vreeland B
    Postgrad Med; 2008 Jul; 120(2):18-33. PubMed ID: 18654065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Schizophrenia and obesity: impact of antipsychotic medications.
    Wirshing DA
    J Clin Psychiatry; 2004; 65 Suppl 18():13-26. PubMed ID: 15600381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Obesity, serious mental illness and antipsychotic drugs.
    Holt RI; Peveler RC
    Diabetes Obes Metab; 2009 Jul; 11(7):665-79. PubMed ID: 19476478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of lifestyle interventions and weight management in schizophrenia.
    Bushe C; Haddad P; Peveler R; Pendlebury J
    J Psychopharmacol; 2005 Nov; 19(6 Suppl):28-35. PubMed ID: 16280335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Managing comorbid obesity and depression through clinical pharmacotherapies.
    McElroy SL; Guerdjikova AI; Mori N; Keck PE
    Expert Opin Pharmacother; 2016 Aug; 17(12):1599-610. PubMed ID: 27280311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychopharmacologic treatment of obesity and eating disorders in children and adolescents.
    Powers PS; Cloak NL
    Child Adolesc Psychiatr Clin N Am; 2012 Oct; 21(4):831-59. PubMed ID: 23040904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychiatric medication-induced obesity: treatment options.
    Schwartz TL; Nihalani N; Virk S; Jindal S; Chilton M
    Obes Rev; 2004 Nov; 5(4):233-8. PubMed ID: 15458397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of weight gain in patients with schizophrenia.
    Aquila R
    J Clin Psychiatry; 2002; 63 Suppl 4():33-6. PubMed ID: 11913674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment-emergent tardive dyskinesia with quetiapine in mood disorders.
    Sharma V
    J Clin Psychopharmacol; 2003 Aug; 23(4):415-7. PubMed ID: 12920421
    [No Abstract]   [Full Text] [Related]  

  • 12. Nutritional aspects of psychiatric disorders.
    Gray GE; Gray LK
    J Am Diet Assoc; 1989 Oct; 89(10):1492-8. PubMed ID: 2677098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Using antipsychotic agents in older patients.
    Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implementing antiobesity treatment in a patient with a mood disorder.
    Taylor VH
    J Psychiatry Neurosci; 2008 Nov; 33(6):E1-2. PubMed ID: 18982178
    [No Abstract]   [Full Text] [Related]  

  • 15. Obesity and related metabolic abnormalities during antipsychotic drug administration: mechanisms, management and research perspectives.
    Baptista T; Kin NM; Beaulieu S; de Baptista EA
    Pharmacopsychiatry; 2002 Nov; 35(6):205-19. PubMed ID: 12518268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antipsychotic medications: metabolic and cardiovascular risk.
    Newcomer JW
    J Clin Psychiatry; 2007; 68 Suppl 4():8-13. PubMed ID: 17539694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implementation of monitoring and management guidelines for second-generation antipsychotics.
    Sernyak MJ
    J Clin Psychiatry; 2007; 68 Suppl 4():14-8. PubMed ID: 17539695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic considerations in the use of antipsychotic medications: a review of recent evidence.
    Newcomer JW
    J Clin Psychiatry; 2007; 68 Suppl 1():20-7. PubMed ID: 17286524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antipsychotic induced weight gain in schizophrenia:mechanisms and management.
    Rege S
    Aust N Z J Psychiatry; 2008 May; 42(5):369-81. PubMed ID: 18473255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Health problems and mental illness.
    Samiee J
    Nurse Pract; 2005 May; 30(5):11. PubMed ID: 15891612
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.